Sleep study for people with pituitary and hypothalamus conditions
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study looks at sleep problems in people whose hypothalamus or pituitary gland does not work normally. It compares their sleep with healthy volunteers to better understand how these conditions affect rest.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a condition affecting your pituitary or hypothalamus, like a hormone deficiency or signs of hypothalamus damage.
- Your hormone levels have been stable and well-managed in the last 6 months.
- You are not taking any new psychiatric medications or using them occasionally.
- You do not have serious liver, lung, kidney, heart, or brain conditions (like stroke, dementia, or uncontrolled seizures).
- You do not have uncontrolled diabetes or active psychosis.
- You have vision of 20/40 or better in at least one eye, no glaucoma, uveitis, or recent eye surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at a specific sleep-related condition (obstructive sleep apnea) in adults whose blood pressure is not high, and how their blood pressure rhythm changes over the day. If you have sleep apnea, participating could help researchers understand patterns that may affect long-term health.
This study looks at sleep and sleep problems in people with neurological conditions like stroke, Parkinson's, epilepsy, or memory issues. You will do a one-night sleep test (polysomnography) and answer questionnaires to help researchers understand your sleep and daytime function.
This study looks at how improving sleep might affect blood vessel health in people with high blood pressure who don't sleep well. You might join if you have high blood pressure and poor sleep quality.
This study looks at how narcolepsy or idiopathic hypersomnia affects thinking and cardiovascular health, and how usual treatment medications may change those outcomes. It may help researchers understand risks and benefits of common hypersomnia therapies.
This trial tests a new medication, HBS-301, in people with idiopathic hypersomnia (a condition causing excessive sleepiness without clear cause). It aims to see if the drug improves wakefulness and is safe.
This study looks at blood samples to understand how sleep loss affects the body. It may help find new ways to diagnose or treat sleep problems.
Hear when a new Hypopituitarism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.